Centering Racial Justice for Black/African American and Indigenous American People in Commercial Tob
Friday, July 15, 2022
Posted by: Natalia Gromov
Breland
AB, Carroll D, Denlinger-Apte R, et al.
Centering Racial Justice
for Black/African American and Indigenous American People in Commercial Tobacco
Product Regulation.
[published online ahead of print, 2022 Jun 15]. Prev Med. 2022;107117.
doi:10.1016/j.ypmed.2022.107117
Although overall health in the United States (US) has improved dramatically
during the past century, long-standing health inequities, particularly the
unequal and unjust burden of tobacco-related disease and death among racialized
populations, persist. A considerable gap exists in our understanding of how
commercial tobacco product regulations and policies cause and/or exacerbate
race-based health inequities among Black/African American (B/AA) and Indigenous
American people. The purpose of this paper is to 1) describe how existing US
commercial tobacco regulatory policies may contribute to structural racism and
undermine the full benefits of tobacco prevention and control efforts among
B/AA and Indigenous American groups; and 2) initiate a call to action for
researchers and regulators of tobacco products to examine policies using an
equity lens. These actions are imperative if empirically-informed regulation of
commercial tobacco products is to address health equity.
|
|